Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Hostettler, J. Halter, D. Lardinois, M. Roth, M. Tamm (Basel, Switzerland). Dose-dependent pro- or anti-proliferative effects of calcineurin inhibitors in bronchiolitis obliterans following allogeneic stem cell transplantation. Eur Respir J 2011; 38: Suppl. 55, 2001

Member's Comments

No comment yet.

Related content which might interest you: Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation Source: Eur Respir J 2014; 43: 221-232 Year: 2004 Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016 Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation Source: Eur Respir J 2011; 38: 470-472 Year: 2011 Bronchiolitis obliterans following haematopoietic stem cell transplantation Source: Eur Respir J 2007; 29: 1007-1019 Year: 2007 Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant Source: Eur Respir J, 52 (1) 1702328; 10.1183/13993003.02328-2017 Year: 2018 Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated? Source: Eur Respir J 2005; 25: 402-405 Year: 2005 Immunosuppressive therapy after human lung transplantation Source: Eur Respir J 2004; 23: 159-171 Year: 2004 Immunosuppressive therapy after human lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105 Year: 2003 Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 179s Year: 2004 Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation Source: Eur Respir J 2004; 23: 440-445 Year: 2004 Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004 Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation. Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings Year: 2018 Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study Source: Eur Respir J 2005; 25: 490-493 Year: 2005 Influence of respiratory viruses on airflow decline after allogenic hematopoietic stem cell transplantation Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Long term follow-up of patients with Bronchiolitis obliterans Syndrome after hematopoietic stem cell transplantation Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantation Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 A model of chronic lung allograft rejection in the rat Source: Eur Respir J 2010; 35: 1354-1363 Year: 2010 Long time decline of lung function in patients with chronic myeloid leukemia after allogeneic stem cell transplantation Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013